Literature DB >> 17390084

A study of innate immunity in patients with end-stage renal disease: special reference to toll-like receptor-2 and -4 expression in peripheral blood monocytes of hemodialysis patients.

Yoshikazu Kuroki1, Kenji Tsuchida, Ishun Go, Masato Aoyama, Toshihide Naganuma, Yoshiaki Takemoto, Tatsuya Nakatani.   

Abstract

It was recently shown that toll-like receptors (TLR) play a critical role in innate immunity. However, no study has been conducted on TLR expression in hemodialysis (HD) patients. The present study was undertaken to examine innate immunity and the roles played by endotoxins (ET) contained in dialysate in HD patients, by analysis of TLR expression and reactivity. TLR-2 and TLR-4 expression on monocytes was investigated by flow cytometry in the following groups of subjects: healthy controls, patients on HD, patients with end-stage renal disease (ESRD) and patients on peritoneal dialysis (PD). The expression of TLRs on monocytes under stimulation with lipopolysaccharide was also investigated. Expression of TLR-4 was lower in the HD group than in the healthy controls (p<0.05), while expression of TLR-2 was lower in the PD group than in the healthy controls (p<0.05). As the duration of dialysis became longer, TLR-4 expression decreased (p<0.01). TLR-2 was not correlated with duration of dialysis, and the magnitude of decrease in TLR-4 expression following stimulation with ET became smaller (p=0.0006). Suppression of expression of TLR-4 was noted in HD patients, and TLR-4 expression was reduced as the duration of dialysis became longer. Reduced TLR-4 expression may be associated with the compromised immune function in HD patients. It seems possible that chronic stimulation with ET suppresses the expression of TLR-4.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17390084

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  20 in total

1.  Low Dietary Intake of Vitamin D and Vitamin D Deficiency in Hemodialysis Patients.

Authors:  Maria Krassilnikova; Katya Ostrow; Amanda Bader; Peter Heeger; Anita Mehrotra
Journal:  J Nephrol Ther       Date:  2014-05-15

Review 2.  Why are sex and gender important to basic physiology and translational and individualized medicine?

Authors:  Virginia M Miller
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-01-10       Impact factor: 4.733

Review 3.  The immunoregulatory function of vitamin D: implications in chronic kidney disease.

Authors:  Kevin A Sterling; Parham Eftekhari; Matthias Girndt; Paul L Kimmel; Dominic S Raj
Journal:  Nat Rev Nephrol       Date:  2012-05-22       Impact factor: 28.314

4.  Primed monocytes: putative culprits of chronic low-grade inflammation and impaired innate immune responses in patients on hemodialysis.

Authors:  Hye Won Kim; Young Seok Woo; Ha Na Yang; Hye Min Choi; Sang Kyung Jo; Won Yong Cho; Hyoung-Kyu Kim
Journal:  Clin Exp Nephrol       Date:  2010-12-09       Impact factor: 2.801

Review 5.  Atherosclerosis in chronic kidney disease: the role of macrophages.

Authors:  Valentina Kon; MacRae F Linton; Sergio Fazio
Journal:  Nat Rev Nephrol       Date:  2010-11-23       Impact factor: 28.314

Review 6.  Microvesicles at the crossroads between infection and cardiovascular diseases.

Authors:  Jing Xiong; Virginia M Miller; Yunman Li; Muthuvel Jayachandran
Journal:  J Cardiovasc Pharmacol       Date:  2012-02       Impact factor: 3.105

Review 7.  Aspects of immune dysfunction in end-stage renal disease.

Authors:  Sawako Kato; Michal Chmielewski; Hirokazu Honda; Roberto Pecoits-Filho; Seiichi Matsuo; Yukio Yuzawa; Anders Tranaeus; Peter Stenvinkel; Bengt Lindholm
Journal:  Clin J Am Soc Nephrol       Date:  2008-08-13       Impact factor: 8.237

8.  Pretreatment Lymphopenia, Poor Performance Status, and Early Courses of Therapy Are Risk Factors for Severe Bacterial Infection in Patients with Multiple Myeloma during Treatment with Bortezomib-based Regimens.

Authors:  Shin Young Hyun; Sang Hoon Han; Soo-Jeong Kim; Ji Eun Jang; Yundeok Kim; Hyunsoo Cho; Jung Yeon Lee; June-Won Cheong; Yoo Hong Min; Jae-Woo Song; Jin Seok Kim
Journal:  J Korean Med Sci       Date:  2016-02-22       Impact factor: 2.153

9.  Cholecalciferol decreases inflammation and improves vitamin D regulatory enzymes in lymphocytes in the uremic environment: A randomized controlled pilot trial.

Authors:  José Tarcisio G Carvalho; Marion Schneider; Lilian Cuppari; Caren C Grabulosa; Danilo T Aoike; Beata Marie Q Redublo; Marcelo C Batista; Miguel Cendoroglo; Rosa Maria Moyses; Maria Aparecida Dalboni
Journal:  PLoS One       Date:  2017-06-30       Impact factor: 3.240

10.  Potential role of the soluble form of CD40 in deficient immunological function of dialysis patients: new findings of its amelioration using polymethylmethacrylate (PMMA) membrane.

Authors:  Cécile Contin-Bordes; Adeline Lacraz; Valérie de Précigout
Journal:  NDT Plus       Date:  2010-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.